BROAD INSTITUTE, INC.
Uncovering genetic determinants of carbapenem resistance in Klebsiella pneumoniae
Uncovering genetic determinants of carbapenem resistance in Klebsiella pneumoniae is a funding opportunity from BROAD INSTITUTE, INC., up to 480650, closing May 31, 2028.
May 31, 2028
(670d left)Overview
Carbapenem-resistant Klebsiella pneumoniae represents an urgent global health threat due to its increasing prevalence and high mortality rates, necessitating a comprehensive understanding of its resistance mechanisms. While key resistance mechanisms and their genetic determinants are known, such as beta- lactamases…